Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Molecular characterisation and origin of the Coffea arabica L. genome.
Molecular & general genetics : MGG·1999
[Irinotecan pharmacokinetics].
Bulletin du cancer·1999
Evolution of immune surveillance and tumor immunity: studies in Xenopus.
Immunological reviews·1999
Successful combined lung and kidney transplantation for pulmonary lymphangioleiomyomatosis and renal angiolipomas.
The European respiratory journal·1999
Ontogeny of CTX expression in xenopus.
Developmental and comparative immunology·1999
[Natal and neonatal teeth. Management].
Annales de pediatrie·1993
[Risks of failure of uncontrolled adoption of foreign children].
Annales de pediatrie·1993
[Hepatic hydatidosis and portal hypertension in children. Is it the Budd-Chiari syndrome?].
Annales de pediatrie·1993
[Neonatal testicular ischemic necrosis without torsion, associated with antithrombin III deficit].
Annales de pediatrie·1993
[Diffuse neonatal hemangiomatosis. A case with tetralogy of Fallot].
Annales de pediatrie·1993
Orbital Septal Fascial Flap with Extensive Release of a Long Orbital Fat Flap for Correcting Lower Eyelid Bags Associated with Midface Depression.
Journal of visualized experiments : JoVE·2026
Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis.
Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity.
Journal of extracellular biology·2026
Prevalence and Associated Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease Across Obesity Metabolic Phenotypes in Chronic Schizophrenia.
International journal of general medicine·2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysis.
Therapeutic advances in neurological disorders·2026